Vineti is a technology startup that provides a comprehensive platform designed to manage the complex workflows involved in personalized cell and gene therapies. The company serves biopharmaceutical and life science companies, focusing on the development and delivery of personalized medicines for patients with complex diseases. Operating in the personalized medicine market, Vineti's business model revolves around offering a robust, agnostic platform that integrates various aspects of the therapy ecosystem, including manufacturing, supply chain, quality control, IT, commercial, and regulatory teams. The platform ensures full transparency, traceability, and control from specimen collection to the delivery of the final product to the patient. Vineti generates revenue through subscription fees for its software solutions and partnerships with therapy developers. The company aims to optimize resources, speed up deployment, and ensure the highest level of care and transparency in the therapeutic process.

Keywords: personalized medicine, cell therapy, gene therapy, biopharmaceutical, life sciences, workflow management, transparency, traceability, supply chain, regulatory compliance.